Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Obstetrics/Gynecology

RSS  

Articles

  • Thank You, John Hobbins; Welcome Camille Hoffman

  • Should All Pregnant Women Be Screened for Hepatitis C?

    In this cost-effectiveness analysis using Markov modeling, investigators found that universal antenatal screening for hepatitis C was cost-effective, with a mean incremental cost-effectiveness ratio of approximately $3,000 per quality-adjusted life years gained compared to risk-based screening.

  • Staged Preeclampsia Screening in Early Pregnancy

    The use of 150 mg of daily aspirin from 11 to 14 weeks through 36 weeks of gestation reduces the rate of early preeclampsia (PE) in approximately 90% of at-risk pregnancies. In addition, aspirin also provides the benefit of reducing the risk of PE < 37 weeks by about 60% and the length of NICU stay by about 70%, primarily by reducing the number of neonates delivered before 32 weeks. What constitutes a high-risk patient and what quantifies patient-specific risks before PE develops remain to be answered.

  • The Changing Face of Labor Management

    Throught the years, clinicians' understanding of the conduct of labor has undergone periodic re-evaluation. In the 1950s, cesarean delivery was a major operation. Today, the procedures are shorter, accompanied by less surgical fanfare, and associated with fewer days in the hospital. Nevertheless, as the only other option to vaginal delivery, the operation, performed in 35% of cases for failure to progress, still should be considered “major” considering its potential for maternal complications.

  • Report Details Effect of Mifepristone Labeling Change

    New research indicates that for Texas providers and patients, the 2016 Food and Drug Administration’s (FDA) new labeling for the abortion drug mifepristone increased access options and brought the proportion of medication abortions in the state into alignment with national data.

  • Test in Development to Detect Preterm Birth

    Scientists at Brigham and Women’s Hospital have published early results of an investigative blood test designed to predict which women may be at increased risk and which ones may be at lower-than-average risk for spontaneous preterm delivery. The researchers have identified circulating microparticle proteins found in blood samples taken in the first trimester of pregnancy that may provide clues about the risk of spontaneous preterm birth.

  • National Plan Aimed at Ending HIV in the United States

    The goal of a new national plan is to end the HIV epidemic in the United States.

  • HPV Immunizations Making Mark on Disease

    In a multi-year analysis of cervical precancers, data indicate that the incidence of cancers caused by human papillomavirus (HPV) types 16 and 18, which have been targeted by vaccination, has declined.

  • Reproductive Health Advocates Push Back Against Proposed Title X Plans

    On March 4, the Trump administration published a final regulation that is a new version of the Reagan administration’s “domestic gag rule.” With the rule’s publication in the Federal Register, a 60-day clock is ticking until provisions of the rule start going into effect.

  • Advanced Research Underway on Potential Copper IUD

    Patient enrollment has begun in the United States for Phase III trials of a new copper intrauterine device (IUD) with a flexible frame.